Imagine a world where the power of nanotechnology offers hope to those facing vision loss due to retinal degeneration. An international team of researchers, led by Prof. Dr. Sedat Nizamoğlu, has crafted a groundbreaking solution. Their innovative technology, published in Science Advances, promises a safer, wireless approach to treating retinal degenerative diseases.
Retinal disorders, affecting millions globally, currently lack a cure. Existing implants face challenges due to their bulkiness and complex electronics. But here's where it gets controversial: the team at Koç University has developed an ultra-thin, biocompatible system that directly converts light into electrical signals, offering a new lease of life to those affected.
The key lies in a photovoltaic nano-assembly, a combination of zinc oxide nanowire arrays and silver-bismuth-sulfide nanocrystals. This structure converts near-infrared light, which is safer and penetrates deeper than visible light, into controlled electrical stimulation without harming ocular tissue. And this is the part most people miss: it operates at low light intensities, well within established safety limits, and is completely wireless, eliminating the need for external cables or complex electronics.
The system's performance was tested on rat retinal models, showing strong and precise responses in retinal neurons. Comprehensive analyses confirmed its safety and long-term stability, with no cellular stress or toxicity. The negligible temperature increase during operation further emphasizes its safety advantages.
What sets this technology apart is its ultra-thin design, use of near-infrared light, and wireless capabilities. These features make it a strong contender not just for visual prosthetics but also for neuromodulation applications targeting various electrically excitable tissues.
Prof. Dr. Nizamoğlu comments, "This study paves the way for potentially restoring vision for individuals with macular degeneration and retinitis pigmentosa. Inorganic nanocrystals, recognized with the 2023 Nobel Prize in Chemistry, offer immense promise for retinal prosthesis technology. Our nanoscale system, operating with near-infrared light, presents a significant alternative to existing approaches. Our findings open doors not only for visual prosthetics but also for a wide range of biomedical applications interacting with the nervous system."
This research, conducted at Koç University, showcases the university's commitment to interdisciplinary research and scientific innovation, offering a brighter future for those living with vision loss.
